CBIO
Crescent Biopharma
CBIO
CBIO
69 hedge funds and large institutions have $111M invested in Crescent Biopharma in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
19% more funds holding
Funds holding: 58 → 69 (+11)
0.03% more ownership
Funds ownership: 0.55% → 0.57% (+0.03%)
Holders
69
Holding in Top 10
–
Calls
$3.4M
Puts
$1.95M
Top Buyers
| 1 | +$2.12M | |
| 2 | +$1.33M | |
| 3 | +$1.02M | |
| 4 |
Jane Street
New York
|
+$697K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$646K |
Top Sellers
| 1 | -$2.79M | |
| 2 | -$632K | |
| 3 | -$549K | |
| 4 |
Two Sigma Advisers
New York
|
-$408K |
| 5 |
AO
Advisor OS
Chicago,
Illinois
|
-$238K |